{"schema":"hottub-news/prospects/v1","item":{"id":"n_gxlyph6yblx23rm3m2eq","title":"FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer","title_en":null,"url":"http://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer","outlet":"United States Food and Drug Administration","published":"2026-11-13T18:22:19Z","sponsored":false,"page":"https://hottub.news/articles/n_gxlyph6yblx23rm3m2eq"},"prospects":[{"name":"United States Food and Drug Administration","kind":"organization","role":"outlet","website":"https://fda.gov/","entity":"wikidata:Q204711","source":"http://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer","note":"Published: FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer (2026-11-13)","reason":"Published “FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer” on 2026-11-13","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=United%20States%20Food%20and%20Drug%20Administration&kind=organization&website=https%3A%2F%2Ffda.gov%2F&source=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fcancer-approvals%2Ffda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer&entity=wikidata%3AQ204711&note=Published%3A%20FDA%20approves%20durvalumab%20with%20enfortumab%20vedotin-ejfv%20for%20muscle%20invasive%20bladder%20cancer%20%282026-11-13%29","propose":{"name":"United States Food and Drug Administration","kind":"organization","reason":"Published “FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer” on 2026-11-13","requestId":"news:n_gxlyph6yblx23rm3m2eq:wikidata:Q204711:51691a38","website":"https://fda.gov/","sourceUrl":"http://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer","entity":"wikidata:Q204711"}}],"someone_else":{"source":"http://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer","note":"In the news: FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer (United States Food and Drug Administration, 2026-11-13)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}